脂肪酸結合蛋白1(FABP1)重組蛋白
Recombinant Fatty Acid Binding Protein 1 (FABP1)
FABP-1; FABPL; L-FABP; LFABP; Liver-type fatty acid-binding protein; Fatty Acid Binding Protein 1, Liver
- 編號RPB566Ra01
- 物種Rattus norvegicus (Rat,大鼠) 相同的名稱,不同的物種。
- 來源原核表達
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細胞定位細胞質(zhì)
- 預測分子量18.0kDa
- 實際分子量18kDa(差異分析請參閱說明書)
- 片段與標簽Met1~Ile127 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點8.9
-
應用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1008 ¥ 2520 ¥ 5040 ¥ 15120 ¥ 37800
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
增值服務
相關產(chǎn)品
編號 | 適用物種:Rattus norvegicus (Rat,大鼠) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB566Ra01 | 脂肪酸結合蛋白1(FABP1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB566Ra01 | 脂肪酸結合蛋白1(FABP1)多克隆抗體 | WB; IHC; ICC; IP. |
MAB566Ra21 | 脂肪酸結合蛋白1(FABP1)單克隆抗體 | WB; IHC; ICC; IP. |
SEB566Ra | 脂肪酸結合蛋白1(FABP1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB566Ra | 脂肪酸結合蛋白1(FABP1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
J Korean Med Sci. | Acute Kidney Injury after Using Contrast during Cardiac Catheterization in Children with Heart Disease [Pubmed:25120320] |
Cryobiology.? | Ex vivo use of a Rho-kinase inhibitor during renal preservation improves graft function upon reperfusion [Pubmed:25555715] |
Clin Transl Sci | Controlled Rewarming after Hypothermia: Adding a New Principle to Renal Preservation [PubMed: 26053383] |
SAGE journals | The role of serum I-FABP concentration in assessment of small intestine mucosa among HIV-infected patients [Content: Early] |
Transplant International | Kidney transplantation after oxygenated machine perfusion preservation with Custodiol‐N solution [PubMed: 25882869] |
European?Journal of?Clinical?Investigation | Prediction of renal function upon reperfusion by ex situ controlled oxygenated rewarming [pubmed:27718228] |
Journal of?Clinical?and Diagnostic?Research? | The Importance of Liver-Fatty Acid Binding Protein in Diagnosis of Liver Damage in Patients with Acute Hepatitis [pubmed:28571184] |
Annals of Nutrition and Metabolism | Plasma Free Fatty Acids and their Binding Proteins in Preterm Infants [Pubmed:30045009] |
Scandinavian Journal of?Clinical?and Laboratory Investigation | Isolated kidney perfusion: the influence of pulsatile flow [Pubmed:29301417] |
International Journal of Medical Sciences | Circulating fatty acid-binding protein 1 (FABP1) and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus [Pubmed: 32038102] |
International Journal of Medical Sciences | FABP1 and FABP2 as markers of diabetic nephropathy [Pubmed: 32922200] |
Archives of Clinical and Biomedical Research | Profile of Intestinal Barrier Functional Markers in Italian Patients with Diarrhea-Predominant IBS: Preliminary Data from a Low-FODMAPs diet Trial [] |
Antioxidants | The Effects of Beverage Intake after Exhaustive Exercise on Organ Damage, Inflammation and Oxidative Stress in Healthy Males [34071378] |
antioxidants | TCA Cycle and Fatty Acids Oxidation Reflect Early Cardiorenal Damage in Normoalbuminuric Subjects with Controlled Hypertension [34356333] |
Association of plasma fatty acid-binding protein 3 with estimated glomerular filtration rate in patients with type 2 diabetes mellitus [34975301] |
留言咨詢